We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Amylin (N-Terminus) antibody
Islet amyloid polypeptide
Amylin
Diabetes-associated peptide (DAP)
Insulinoma amyloid peptide
IAPP, IAP
Amylin
Diabetes-associated peptide (DAP)
Insulinoma amyloid peptide
IAPP, IAP
Out of stock
Ref
00020240
Selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle, while not affecting adipocyte glucose metabolism.
| ID Covalab | pab72563 |
|---|---|
| Product type | Primary antibodies |
| Clonality | Polyclonal antibody |
| Raised in | Rabbit |
| Immunogen | Synthetic peptide derived from N-terminus of human Amylin peptide. |
| Activity cross reaction | Reacts with the N-terminus part of human Amylin. |
| Species | Hu |
| Labelling | None |
| Form | Antigen affinity purified |
| Preservative | NaN3 |
| Storage instructions | +4°C or -20°C, Avoid repeated freezing and thawing. |
| Target | Amylin |
| Accession Number | P10997 |
| Applications | IHC - P |
| Working dilutions | IHC-P (10 µg/ml) |
Write Your Own Review